相关实验视频
Updated: Jun 28, 2025
05:17
Intravenous Injections in Neonatal Mice
Published on: November 11, 2014
58.7K
在最大的波浪上保持平衡:为新生儿提供Nirsevimab.
Neonatal network : NN
|April 10, 2024
概括
一种新的单克隆抗体,nirsevimab,通过单剂量在婴儿中提供季节性保护,防止严重的呼吸道同胞病毒 (RSV) 疾病. 这一进步为预防RSV导致婴儿住院的情况提供了更方便和更有效的选择.
科学领域:
- 儿科 儿科 儿科
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 呼吸道同胞性病毒 (RSV) 是美国婴儿住院的主要原因,几乎所有2岁儿童都受到影响.
- 严重的RSV疾病可能导致长期健康问题,如喘和言语发育迟缓.
- 像帕利维祖马布这样的现有干预措施是昂贵的,需要多次剂量,限制了它们的广泛使用.
研究的目的:
- 评估nirsevimab的疗效和安全性,这是一种新型单克隆抗体,用于预防婴儿严重RSV疾病.
- 评估尼尔塞维玛布作为单剂,全季预防性预防RSV住院治疗措施的潜力.
主要方法:
- 进行了四项具有里程碑意义的随机对照试验,涉及健康和高风险婴儿 (早产和终产).
- 尼尔塞维马布向RSV预注射F蛋白的Ø抗原位.
- 对减少医疗护理的RSV疾病和住院治疗的监测有效性,以及安全性概况.
主要成果:
- 尼尔塞维马布显著降低了医疗护理的RSV疾病 (NNT 14-24) 和住院 (NNT 33-63) 的风险.
- 一次剂量为整个5个月的RSV季节提供了保护.
- 观察到罕见的副作用,主要是轻微的皮疹和注射部位反应.
结论:
- 尼尔塞维马布是一种有效和安全的单剂预防疗法,用于婴儿严重RSV疾病.
- 最近的CDC建议支持为8个月以下的婴儿和8-19个月的高风险婴儿使用nirsevimab.
- 公平的分配和多学科的合作对于成功实施nirsevimab治疗至关重要.
相关概念视频
01:22Development of Immunocompetence
305
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
305
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K